ADAP

Public Comment by The AIDS Institute before the Presidential Advisory Council on HIV/AIDS

PUBLIC COMMENT by CARL SCHMID, DEPUTY EXECUTIVE DIRECTOR, THE AIDS INSTITUTE
before the PRESIDENTIAL ADVISORY COUNCIL ON HIV/AIDS

January 27, 2011
Washington, DC

12.10.10 - TAI Press Release: U.S. House of Representatives Increases AIDS Drug Funding by $60 Million

Washington, D.C. - In a significant victory for people living with HIV/AIDS in the United States, the U.S. House of Representatives has approved an additional $60 million for the financially struggling AIDS Drug Assistance Program (ADAP) in fiscal year 2011.

The AIDS Institute's Public Comment before the CDC/HRSA Advisory Committee on HIV & STD Prevention and Treatment

PUBLIC COMMENT by CARL SCHMID DEPUTY EXECUTIVE DIRECTOR of THE AIDS INSTITUTE
before the
CDC/HRSA ADVISORY COMMITTEE ON HIV AND 
STD PREVENTION AND TREATMENT
November 16, 2010

HRSA

The AIDS Institute Statement on Programs to Support During the FY11 Appropriations Conference Process

The AIDS Institute would particularly like the Committees to focus on increased funding for the Ryan White AIDS Drug Assistance Program (ADAP) and HIV prevention funding at the Centers for Disease Control and Prevention (CDC).
November 4, 2010
Washington, DC

Statement to the Subcommittee on Labor, Health and Human Services, Education, and Related Agencies

Written Statement of Carl Schmid, Deputy Executive Director,the Aids Institute to the Subcommittee on Labor, Health and Human Services, Education, and Related Agencies House Committee on Appropriations.
April 12, 2010

Syndicate content